Pfizer Animal Health Adds Former Schering-Plough Products to European Portfolio
FRANCE - Pfizer Animal Health has announced that its acquisition of multiple product franchises in Europe from the Schering-Plough Corporation has been completed and approved by the European Commission. Pfizer has acquired these assets for approximately €116 million in cash.
11 September 2008
1 minute read
The acquisition adds both biological and pharmaceutical products across the major animal health species including cattle, swine, equine and companion animal to Pfizer’s portfolio. Pfizer has acquired certain rights to the following products in the European Economic Area:
"This represents a significant expansion of our product portfolio and strengthens our long term commitment not just to veterinary surgeons, but also to farmers and pet owners,” said Albert Bourla, Pfizer Animal Health’s area president, Europe, Africa, Middle East.
"Pfizer now has the most in-depth coverage of therapeutic areas in Europe, and the most highly recognized brands in the industry," Mr Bourla said.
TheCattleSite News Desk
